跳至主要内容
临床试验/EUCTR2005-000474-42-IT
EUCTR2005-000474-42-IT进行中(未招募)不适用

Safety and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in hypertensive children having received S 90652 - an open, non-comparative, 24-month (minimal duration), multicentre study.

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER0 个研究点目标入组 60 人开始时间: 2007年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children older than 2 years and 3 months Having reached the termination visit of the CL2-90652-001 after 3 months of treatment maintenance on S 90652 In whom th S 90652 treatment administered during the CL2-90652-001 study is considered by the investigator as well tolerated and fairly active on BP level
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Poorly controlled hypertension defined as a SBP or a DBP >o= 97.5th percentile; Girls with signs of pubescence; Estimated GFR < 25 mL/min/1.73m2 calculed from the modified Schwarts formula; Serum potassium level > 5,5 mmol/l on a recent laboratory exam

研究者

相似试验